Tharimmune, Inc. (THAR)
NASDAQ: THAR · Real-Time Price · USD
1.205
+0.035 (3.01%)
Apr 23, 2025, 4:00 PM EDT - Market closed
Tharimmune Market Cap
Tharimmune has a market cap or net worth of $2.54 million as of April 24, 2025. Its market cap has decreased by -51.67% in one year.
Market Cap
2.54M
Enterprise Value
-1.02M
1-Year Change
-51.67%
Ranking
Category
Stock Price
$1.21
Market Cap Chart
Since the IPO on January 12, 2022, Tharimmune's market cap has decreased from $41.18M to $2.54M, a decrease of -93.83%. That is a compound annual growth rate of -57.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 22, 2025 | 2.47M | -37.16% |
| Dec 31, 2024 | 3.93M | 205.38% |
| Dec 29, 2023 | 1.29M | -71.40% |
| Dec 30, 2022 | 4.49M | -89.09% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 734.57B |
| UnitedHealth Group | 387.15B |
| Johnson & Johnson | 378.15B |
| AbbVie | 301.01B |
| Novo Nordisk | 284.50B |
| Abbott Laboratories | 225.27B |
| Novartis AG | 209.93B |
| AstraZeneca | 208.11B |